Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated Gait and Pose Analysis Utilizing Computer Vision for Parkinsonian Behavioral Phenotyping in Mice.

bioRxiv : the preprint server for biology·2026
Same author

Detection of phosphorylated α-synuclein in skin - Authors' reply.

The Lancet. Neurology·2026
Same author

Targeted antisense oligonucleotide treatment rescues developmental alterations in spinal muscular atrophy organoids.

Nature communications·2025
Same author

Stroke Survivors Have Almost Three Times Higher Risk of Depression: A Systematic Review and Meta-Analysis.

Journal of clinical medicine·2025
Same author

Maternal Genotype and Dietary Vitamin A Modify Aortic Arch Phenotypes in a Mouse Model of 22q11DS.

International journal of molecular sciences·2025
Same author

Plasma proteomics uncovers divergent molecular signatures in ischemic stroke and intracerebral hemorrhage.

Biomarker research·2025

Related Experiment Video

Updated: Jun 6, 2026

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
09:29

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

Mitophagy: the latest problem for Parkinson's disease.

Cristofol Vives-Bauza1, Serge Przedborski

  • 1Department of Neurology, Columbia University, New York, NY, USA.

Trends in Molecular Medicine
|December 15, 2010
PubMed
Summary

Parkinson's disease (PD) involves PTEN-induced kinase-1 (PINK1) and Parkin genes, crucial for mitochondrial degradation (mitophagy). Understanding this pathway offers insights into inherited and sporadic PD pathogenesis and therapy.

More Related Videos

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

Related Experiment Videos

Last Updated: Jun 6, 2026

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
09:29

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

Area of Science:

  • Neurodegenerative diseases
  • Mitochondrial biology
  • Genetics of Parkinson's disease

Background:

  • Parkinson's disease (PD) is a prevalent neurodegenerative disorder with largely unknown etiology.
  • Familial forms of PD are linked to mutations in PTEN-induced kinase-1 (PINK1) and Parkin genes.
  • PINK1 and Parkin are implicated in mitophagy, the selective degradation of damaged mitochondria.

Purpose of the Study:

  • To review recent advances in understanding the PINK1/Parkin pathway.
  • To elucidate the molecular mechanisms by which PINK1 and Parkin regulate mitophagy.
  • To explore the implications of PINK1/Parkin biology for Parkinson's disease pathogenesis and treatment.

Main Methods:

  • Literature review of studies on PINK1, Parkin, and mitophagy.
  • Analysis of genetic and molecular data related to familial and sporadic Parkinson's disease.
  • Synthesis of current knowledge on the PINK1/Parkin signaling pathway.

Main Results:

  • The PINK1/Parkin pathway plays a critical role in mediating mitophagy.
  • Specific molecular mechanisms linking PINK1 and Parkin to mitochondrial clearance are being uncovered.
  • Evidence suggests a conserved function for this pathway in both inherited and sporadic forms of PD.

Conclusions:

  • The PINK1/Parkin pathway is central to mitochondrial quality control and has significant implications for Parkinson's disease.
  • Further research into PINK1/Parkin biology may yield novel therapeutic strategies for Parkinson's disease.
  • Understanding these genetic factors could illuminate the broader pathogenic mechanisms of PD.